Donald J Santel is a director of Aerovate Therapeutics Inc.
Person profile
Roles
Aerovate Therapeutics
Director
Oyster Point Pharma
Director
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aerovate Therapeutics, Inc.
4 Jan 24
4
Aerovate Therapeutics, Inc.
8 Jun 23
4
Aerovate Therapeutics, Inc.
23 Jan 23
3
Aerovate Therapeutics, Inc.
23 Jan 23
4
Oyster Point Pharma, Inc.
4 Jan 23
4
Oyster Point Pharma, Inc.
8 Jun 22
4
Surrozen, Inc./DE
13 Aug 21
4
Oyster Point Pharma, Inc.
3 Aug 21
3
Oyster Point Pharma, Inc.
3 Aug 21
3
Consonance-HFW Acquisition Corp.
18 Nov 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | AVTE Aerovate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 13.49 | 2,889 | 38.97 k | 2,889 |
6 Jun 23 | AVTE Aerovate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 16.3 | 12,500 | 203.75 k | 12,500 |
19 Jan 23 | AVTE Aerovate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 15.48 | 2,519 | 38.99 k | 2,519 |
19 Jan 23 | AVTE Aerovate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 23.44 | 25,000 | 586.00 k | 25,000 |
3 Jan 23 | OYST Oyster Point Pharma | Common Stock | Sale back to company | Dispose D | No | No | 0 | 8,198 | 0.00 | 0 |
3 Jan 23 | OYST Oyster Point Pharma | Common Stock | Dispose U | No | No | 0 | 5,489 | 0.00 | 8,198 | |
3 Jan 23 | OYST Oyster Point Pharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.63 | 5,359 | 19.45 k | 0 |
3 Jan 23 | OYST Oyster Point Pharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 14.25 | 15,170 | 216.17 k | 0 |